Thomson Medical (SGX:A50) booked a loss attributable to owners of the company of SG$12.9 million for the six months ended Dec. 31, 2024, against an attributable profit of SG$2.0 million a year earlier, a filing with the Singapore Exchange said on Wednesday.
Loss per share came in at SG$0.00049 compared with earnings per share of SG$0.00008 in the comparable period.
Revenue was, however, up 18% year over year to SG$199.1 million from SG$168.1 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。